A qualitative analysis of the psychedelic mushroom come-up and come-down.
Ari Brouwer, Joshua K Brown, Earth Erowid, Fire Erowid, Sylvia Thyssen, Charles L. Raison, Robin Carhart-Harris
npj Mental Health Research February 7, 2025 DOI: 10.1038/s44184-024-00095-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Population | Self-reported psilocybin or psilocybin-containing mushroom experience reports submitted to Erowid.org |
| Intervention | Psilocybin |
| Topics | Psilocybin |
| Keywords | Stress relief Psychedelics Mental health Altered states Therapeutic effects |
| Citations | 5 |
| Key findings | The come-up phase of psychedelic experiences is more often characterized by negatively valenced feeling states resembling an acute stress reaction, while the come-down phase is more often characterized by positively valenced feeling states similar to recovery from illness or stress resolution. |
Abstract
Psychedelic therapy has the potential to become a revolutionary and transdiagnostic mental health treatment, yielding enduring benefits that are often attributed to the experiences that coincide with peak psychedelic effects. However, there may be an underrecognized temporal structure to this process that helps explain why psychedelic and related altered states of consciousness can have an initially distressing but ultimately distress-resolving effect. Here we present a qualitative analysis of the self-reported 'come-up' or onset phase, and 'come-down' or falling phase, of the psychedelic experience. Focusing on psilocybin or psilocybin-containing mushroom experience reports submitted to Erowid.org, we use phenomenological, thematic content and word frequency analysis to show that the come-up is more often characterized by negatively valenced feeling states that resemble an acute stress reaction, while the come-down phase is more often characterized by positively valenced feeling states of the sort often observed following recovery from illness or resolution of stress. The therapeutic and theoretical relevance of these findings are discussed.
Citations in the library
Cited by 8
- Key competencies for psychedelic treatment in real-world mental health care settings. General Hospital Psychiatry 2025
- The psychedelic-peptide paradox: a hormetic hypothesis. Comprehensive Psychoneuroendocrinology June 2, 2025
- Fearful symmetry in altered states: a bi-logic account of psychedelic action. Frontiers in Psychology August 19, 2025
- A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants medRxiv December 23, 2025
- Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study CNS Drugs August 7, 2026
and 3 more in the library
Cites 28
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
and 23 more in the library